One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
Congratulations to Milei for Winning Free Market Mandate in Argentina
-
The polls and analysts were wildly wrong on this one.
2 hours ago
No comments:
Post a Comment